(Press-News.org) SALT LAKE CITY, Utah, May 13, 2015 - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced it will present data from 19 clinical studies at the 2015 American Society of Clinical Oncology annual meeting to be held May 29 to June 2, 2015 in Chicago, Ill. Key podium presentations will highlight new prospective research programs with advanced companion diagnostic and molecular diagnostic tests aimed at revolutionizing how we treat and prevent cancers. Abstracts of the Company's presentations are available at: abstracts.asco.org.
"Advances in personalized medicine will include selecting effective pharmaceuticals (companion diagnostics), preventing disease (hereditary caner tests) and in optimizing treatment decisions (prognostic tests). This meeting showcases our pioneering research in these three areas of personalized medicine. In companion diagnostics, the myChoice™ HRD test can transform the way we personalize treatment plans for ovarian and breast cancers today and many other cancers in the future," said Mark Capone, president Myriad Genetic Laboratories. "Another critical goal for personalized medicine is to prevent cancer. Our myRisk™ hereditary cancer panel test does just that by analyzing 25 genes associated with eight common hereditary cancers. Lastly, our prognostic tests demonstrate advances in optimizing treatments decisions in prostate cancer and lung cancer. As a pioneer in the field of personalized medicine, we remain firmly committed to scientific progress through outstanding research that can ultimately benefit patients."
The list of key Myriad presentations follows.
1. COMPANION DIAGNOSTIC PRESENTATIONS
myChoice HRD™: Podium Presentation
Title: Prediction of pathological complete response (pCR) by homologous recombination deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC: results from GeparSixto.
Presenter: Gunter Von Minckwitz
Date: Monday, June 1, 4:12 - 4:24 p.m.
Location N Hall B1; Abstract: 1004
myChoice HRD: Poster Discussion Sessions
Title: Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early stage breast cancer (NCT01372579).
Presenter: Virginia Kaklamani
Date: Saturday, May 30, 8:00 to 11:30 a.m.
Location: N Hall B1; Abstract: 1017, Poster: 131
Title: Combined homologous recombination deficiency (HRD) scores and response to neoadjuvant platinum-based chemotherapy in triple negative and/or BRCA1/2 mutation associated breast cancer.
Presenter: Melinda Telli
Date: Saturday, May 30, 8:00 to 11:30 a.m.
Location: N Hall B1; Abstract: 1018, Poster: 132
myChoice HRD: Poster Sessions
Title: Reproducibility of homologous recombination deficiency (HRD) scores in biopsies of triple negative breast cancer (TNBC) tumors.
Presenter: Kirsten Timms
Date: Saturday, May 30, 8:00 to 11:30 a.m.
Location: Abstract: 1091, Poster: 205
Title: Association of tumor BRCA1 reversion mutation arising during neoadjuvant platinum-based therapy in breast cancer (BC) with therapy resistance.
Presenter: Anosheh Afghahi
Date: Saturday, May 30, 8:00 to 11:30 a.m.
Location: Abstract: 1094, Poster: 208
Title: Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC).
Presenter: Jai Patel
Date: Saturday, May 30, 1:15 to 4:45 p.m.
Location: Abstract: 5534, Poster: 92
Title: Use of homologous recombination deficiency (HRD) score to enriche for niraparib sensitive high grade ovarian tumors.
Presenter: Keith Wilcoxen
Date: Saturday, May 30, 1:15 to 4:45 p.m.
Location: Abstract: 5532, Poster: 90
Title: Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).
Presenter: Robert Brown
Date: Saturday, May 30, 1:15 to 4:45 p.m.
Location: Abstract: 5576, Poster: 134
BRACAnalysis CDx™: Poster Session
Title: A randomized, placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with AZD 1775 (MK 1775) in women with recurrent, platinum-resistant epithelial ovarian, primary peritoneal or Fallopian tube cancers: Trial of Princess Margaret, Mayo, Chicago, and California consortia.
Presenter: Stephanie Lheureux
Date: Saturday, May 30, 1:15 to 4:45 p.m.
Location: Abstract: TPS5613, Poster: 167a
2. HEREDITARY CANCER PRESENTATIONS
myRisk™ Hereditary Cancer: Podium Presentation
Title: Predisposing germline mutations in high grade ER+HER2- breast cancer (BC) patients diagnosed END
Myriad showcases its pioneering research at the 2015 ASCO Annual Meeting
19 presentations will highlight Myriad's expanding portfolio of transformative diagnostic tests
2015-05-14
ELSE PRESS RELEASES FROM THIS DATE:
Economic burden of cancer extends into survivorship
2015-05-14
A new study finds the economic burden of cancer extends beyond diagnosis and treatment, and concludes that cancer survivors face thousands of dollars of excess medical expenses every year as well as excess employment disability and loss of production at work. The study abstract is being presented at the upcoming ASCO Annual Meeting and was released online today.
Researchers led by Zhiyuan "Jason" Zheng examined the economic burden among survivors of the three most prevalent cancers (colorectal, female breast, and prostate) in nonelderly and elderly populations in the ...
Medical marijuana pill may not be effective in treating behavioral symptoms of dementia
2015-05-13
MINNEAPOLIS - A new study suggests that medical marijuana pills may not help treat behavioral symptoms of dementia, such as aggression, pacing and wandering. The research is published in the May 13, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology. However, researchers did find that the drug dosage used in the clinical trial was safe and well-tolerated.
"Our study results are valuable since any firm evidence of the effectiveness and safety of medical marijuana in this disease area is scarce," said study author Geke A.H. van ...
Long-term depression may double stroke risk despite treatment
2015-05-13
DALLAS, May 13, 2015 -- Persistent depression may double the risk of stroke in adults over 50 -- and stroke risk remains higher even after symptoms of depression go away, according to research in the Journal of the American Heart Association.
"Our findings suggest that depression may increase stroke risk over the long term," said Paola Gilsanz, Sc.D., study lead author and ?Yerby Postdoctoral Research Fellow at Harvard University's T.H. Chan School of Public Health in Boston, Mass.
Researchers used data from 16,178 participants (ages 50 and older) who had been interviewed ...
Long-term depression may double stroke risk for middle-aged adults
2015-05-13
Boston, MA -- Adults over 50 who have persistent symptoms of depression may have twice the risk of stroke as those who do not, according to a new study led by researchers at Harvard T.H. Chan School of Public Health. Researchers found that stroke risk remains higher even after symptoms of depression go away, particularly for women.
The study will be published online May 13, 2015 in the Journal of the American Heart Association.
"This is the first study evaluating how changes in depressive symptoms predict changes in stroke risk," said lead author Paola Gilsanz, Yerby ...
A SMARTer approach to stroke care
2015-05-13
Time is critical when it comes to stroke, and early treatment is associated with better outcomes. According to the Screening with MRI for Accurate and Rapid stroke Treatment (SMART) study, small changes in quality improvement procedures enabled clinicians to use MRI scans to diagnose stroke patients before giving acute treatment, within 60 minutes of hospital arrival. MRI scans provide detailed images but take longer to complete than CT scans, which are commonly used in most centers. The findings, published in Neurology, were supported in part by the National Institutes ...
TGen study matches infant stiff-joint syndromes to possible genetic origins
2015-05-13
PHOENIX, Ariz. -- May 13, 2015 -- A study led by the Translational Genomics Research Institute (TGen) has for the first time matched dozens of infantile diseases and syndromes involving muscle weakness and stiff joints to their likely genetic origins.
The study, in association with the University of British Columbia and BC Children's Hospital Vancouver, was published this month (May) in the American Journal of Medical Genetics. The study's goal is to better enable physicians and geneticists to advance new treatments that might help these children.
"It's amazing to us ...
Saving critical time diagnosing stroke patients with MRI by borrowing 'lean' principles
2015-05-13
Washington, D.C., May 13, 2015 -- Using efficiency principles borrowed from "lean" manufacturing processes, two Washington-area hospitals have gotten a life-saving drug to stroke patients significantly quicker, while also obtaining better diagnostic information using MRI. That's according to a new study published online ahead of print in the May 13 issue of Neurology®, the medical journal of the American Academy of Neurology.
National benchmarks call for getting stroke patients from the door of the emergency room to injection with the clot-busting drug known as ...
UM study uncovers why songbirds vary in time devoted to warming eggs
2015-05-13
MISSOULA -- The amount of time and effort songbirds spend warming their eggs directly correlates to their own survival probability and that of their eggs, according to a study by University of Montana researchers that will appear in an upcoming issue of The American Naturalist.
The amount of care parents provide their young varies greatly across the animal kingdom, particularly among songbird species, who spend anywhere from 20 percent to nearly 100 percent of daylight hours warming eggs in their nests. A team of researchers led by Thomas Martin, senior scientist and ...
Vitamin D levels predict survival chances for sick cats, study finds
2015-05-13
Cats may hold vital clues about the health benefits of vitamin D, a study suggests.
Researchers found that higher levels of vitamin D are linked to better survival chances for hospitalised pet cats.
Cats could prove useful for investigating the complex link between vitamin D and a range of health problems that also affect people, the researchers say.
The findings may also help vets to give owners better advice about their pets' prognosis, according to researchers at the University of Edinburgh's Royal (Dick) School of Veterinary Studies.
Researchers examined blood ...
Burmese long-tailed macaque stone-tool use catalogued
2015-05-13
Eighty percent of a population of Burmese long-tailed macaques on an island in southern Thailand use stone and shell tools to crack open seafood, and do so using 17 different action patterns, according to a study published May 13, 2015 in the open-access journal PLOS ONE by Amanda Tan from Nanyang Technological University, Singapore, and colleagues, under an 8 year field project led by Michael D Gumert, also from NTU.
The authors of the study explored variation in how Burmese long-tailed macaques used percussive stone and shell tools to hammer coastal foods on Piak Nam ...
LAST 30 PRESS RELEASES:
Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer
European study offers clearer picture of childhood brain tumor survival
The Lancet: Three in five liver cancer cases due to preventable risk factors; obesity-linked cases on the rise, new analysis suggest
Tiny artificial cells can keep time, study finds
How aging quiets lupus and brings relief to some older patients
Research alert: Synergistic treatment approach supercharges cancer immunotherapy
White veteran high users of online portal generate and exchange more messages than certain patient minorities in the Veterans Health Administration
Web-based tool helps Michigan physicians navigate diabetes coverage and prior authorization
Most primary care patients with opioid use disorder who start treatment stay engaged
U.S.-born Latinos have higher rates of obesity compared to foreign-born Latino and white youth
Study finds veterans experiencing homelessness who gain housing are more likely to get colorectal and breast cancer screenings
Body fat percentage beats BMI in predicting 15-year mortality risk among U.S. adults ages 20 to 49
Umbrella review summarizes family physicians’ experiences with clinical integration
HEAL protocol addresses human trafficking in Brazilian primary care
Study finds uneven progress toward diabetes goals across patient groups in the enhanced primary care diabetes program
Veterans experiencing homelessness who secure housing more likely to get cancer health screenings
Family physicians improve rural maternity outcomes but those in high-need states need support
Tip sheet summaries Annals of Family Medicine July/August 2025
TFLN-based RGB multiplexer for energy-efficient laser beam scanning
On a Florida bombing range, endangered woodpeckers get a second chance
Study identifies gene clusters in rhizobia linked to robust legume growth
Remapping the evolutionary tree of butterflies
Employees who spot problems help the bottom line, so why do leaders give more power to bootlickers?
Could living near water mean you’ll live longer?
Alcohol withdrawal syndrome linked to worse surgical outcomes, higher costs
US POINTER trial: Structured lifestyle intervention delays cognitive decline
Detecting a potential behavioral biomarker for Parkinson’s disease in mice
Expectations about pain influence the experience in different ways
Landmark sleep study links objective sleep patterns with 172 diseases—regularity matters more than duration
Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment
[Press-News.org] Myriad showcases its pioneering research at the 2015 ASCO Annual Meeting19 presentations will highlight Myriad's expanding portfolio of transformative diagnostic tests